[IGF2R-A2/B2 variant probably provides a selective advantage for non-small cell lung cancer progression through increased tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE